Reuters logo
BRIEF-Akorn receives FDA approval for ephedrine sulfate injection, USP
March 2, 2017 / 1:53 PM / 9 months ago

BRIEF-Akorn receives FDA approval for ephedrine sulfate injection, USP

March 2 (Reuters) - Akorn Inc:

* Akorn receives FDA approval for ephedrine sulfate injection, USP

* Akorn Inc says received approval from FDA for its new drug application for ephedrine sulfate injection, USP 50 mg/ml in 1 ml single dose ampule

* Akorn Inc - ephedrine sulfate injection is indicated for “treatment of clinically important hypotension occurring in setting of anesthesia” Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below